DK0966285T3 - Anvendelse af (+)mefloquin til behandling af malaria - Google Patents
Anvendelse af (+)mefloquin til behandling af malariaInfo
- Publication number
- DK0966285T3 DK0966285T3 DK98910836T DK98910836T DK0966285T3 DK 0966285 T3 DK0966285 T3 DK 0966285T3 DK 98910836 T DK98910836 T DK 98910836T DK 98910836 T DK98910836 T DK 98910836T DK 0966285 T3 DK0966285 T3 DK 0966285T3
- Authority
- DK
- Denmark
- Prior art keywords
- quinolinemethanol
- piperidinyl
- trifluoromethyl
- alpha
- bis
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 title abstract 3
- XEEQGYMUWCZPDN-SWLSCSKDSA-N (+)-(11R,2'S)-erythro-mefloquine Chemical compound C([C@H]1[C@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-SWLSCSKDSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704809.4A GB9704809D0 (en) | 1997-03-07 | 1997-03-07 | Chemical compounds |
| GBGB9722232.7A GB9722232D0 (en) | 1997-10-21 | 1997-10-21 | Chemical compounds |
| GBGB9724263.0A GB9724263D0 (en) | 1997-11-17 | 1997-11-17 | Chemical compounds |
| GBGB9724712.6A GB9724712D0 (en) | 1997-11-21 | 1997-11-21 | Chemical compounds |
| PCT/GB1998/000675 WO1998039003A1 (en) | 1997-03-07 | 1998-03-06 | Use of (+)mefloquine for the treatment of malaria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0966285T3 true DK0966285T3 (da) | 2002-10-28 |
Family
ID=27451612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98910836T DK0966285T3 (da) | 1997-03-07 | 1998-03-06 | Anvendelse af (+)mefloquin til behandling af malaria |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6664397B1 (da) |
| EP (1) | EP0966285B1 (da) |
| JP (1) | JP4380800B2 (da) |
| AT (1) | ATE225177T1 (da) |
| AU (1) | AU730818B2 (da) |
| DE (1) | DE69808440T2 (da) |
| DK (1) | DK0966285T3 (da) |
| ES (1) | ES2185153T3 (da) |
| PT (1) | PT966285E (da) |
| WO (1) | WO1998039003A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197788B1 (en) * | 1997-11-26 | 2001-03-06 | Vernalis Research Limited | (−)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders |
| GB0021776D0 (en) | 2000-09-05 | 2000-10-18 | Arakis Ltd | The treatment of inflammatory disorders |
| GB0406014D0 (en) * | 2004-03-17 | 2004-04-21 | Arakis Ltd | Pharmaceutical composition and use |
| WO2006138487A2 (en) * | 2005-06-14 | 2006-12-28 | The Johns Hopkins University | Treatment of ischemia-induced arrhythmias |
| WO2007098047A2 (en) * | 2006-02-16 | 2007-08-30 | The Mclean Hospital Corporation | Methods and compositions for the treatment of parkinson's disease |
| WO2009131657A1 (en) * | 2008-04-21 | 2009-10-29 | Duke University | Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones |
| SG174483A1 (en) * | 2009-03-24 | 2011-10-28 | Univ Singapore | Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd) |
| US8716265B2 (en) | 2010-11-18 | 2014-05-06 | Jenrin Discovery, Inc. | 4-quinolinemethanols as anti-malarial agents |
| EP2487157A1 (en) | 2011-02-11 | 2012-08-15 | Université de Picardie Jules Verne | Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use |
| MX378538B (es) * | 2012-08-09 | 2025-03-10 | Can Fite Biopharma Ltd | Ligandos del receptor de adenosina a3 para su uso en el tratamiento de una disfuncion sexual. |
| CN103304538B (zh) * | 2013-06-21 | 2014-12-24 | 中国人民解放军第四军医大学 | 右旋甲氟喹的合成 |
| CN107149601B (zh) * | 2017-05-25 | 2020-04-17 | 中国中医科学院中药研究所 | 青蒿素类化合物在制备治疗神经病理性疼痛和/或并发症的药物中的应用 |
| CN111527068A (zh) | 2017-11-03 | 2020-08-11 | 皮卡第儒勒-凡尔纳大学 | 新型氨基吡啶甲醇化合物及其用途 |
| CN110507646A (zh) * | 2019-09-12 | 2019-11-29 | 广州中医药大学(广州中医药研究院) | 青蒿素衍生物在制备抗焦虑症的药物或缓解焦虑症的食品中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3630200A (en) | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| DE2940443A1 (de) | 1979-10-05 | 1981-04-16 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von erythro-(alpha)-2-piperidyl-2,8-bis-(trifluormethyl)-4-chinolin-methanol |
| GB8322007D0 (en) | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
| US4769027A (en) | 1984-08-15 | 1988-09-06 | Burroughs Wellcome Co. | Delivery system |
-
1998
- 1998-03-06 WO PCT/GB1998/000675 patent/WO1998039003A1/en not_active Ceased
- 1998-03-06 DK DK98910836T patent/DK0966285T3/da active
- 1998-03-06 AT AT98910836T patent/ATE225177T1/de not_active IP Right Cessation
- 1998-03-06 ES ES98910836T patent/ES2185153T3/es not_active Expired - Lifetime
- 1998-03-06 JP JP53828198A patent/JP4380800B2/ja not_active Expired - Lifetime
- 1998-03-06 AU AU65068/98A patent/AU730818B2/en not_active Ceased
- 1998-03-06 EP EP98910836A patent/EP0966285B1/en not_active Expired - Lifetime
- 1998-03-06 DE DE69808440T patent/DE69808440T2/de not_active Expired - Fee Related
- 1998-03-06 PT PT98910836T patent/PT966285E/pt unknown
- 1998-03-06 US US09/380,353 patent/US6664397B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4380800B2 (ja) | 2009-12-09 |
| DE69808440T2 (de) | 2003-07-10 |
| HK1024631A1 (en) | 2000-10-20 |
| AU730818B2 (en) | 2001-03-15 |
| AU6506898A (en) | 1998-09-22 |
| WO1998039003A1 (en) | 1998-09-11 |
| JP2001526637A (ja) | 2001-12-18 |
| EP0966285B1 (en) | 2002-10-02 |
| ATE225177T1 (de) | 2002-10-15 |
| DE69808440D1 (de) | 2002-11-07 |
| ES2185153T3 (es) | 2003-04-16 |
| US6664397B1 (en) | 2003-12-16 |
| PT966285E (pt) | 2002-12-31 |
| EP0966285A1 (en) | 1999-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700232A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
| DK0959888T3 (da) | Anvendelse af det chelerende middel clioquinol til fremstillingen af et farmaceutisk præparat til behandlingen af Alzheimer's sygdom | |
| CZ309247B6 (cs) | 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru | |
| EA200101156A1 (ru) | ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ | |
| PT966285E (pt) | Utilizacao de (+)mefloquina para o tratamento da malaria | |
| DK1223980T3 (da) | Anvendelse af CSF-1-inhibitorer | |
| ATE376832T1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| WO2000071108A3 (en) | Methods for treatment of asthma using s-oxybutynin | |
| DK0966277T3 (da) | Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom | |
| DE60026491D1 (de) | Melagatran zur behandlung von entzündungen | |
| DE69627160D1 (de) | Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma-butyrobetain für die behandlung von herz-gefäss-erkrankungen | |
| EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
| GEP20063754B (en) | Quinoline Derivatives and Use Thereof as Antitumor Agents | |
| DK0799618T3 (da) | Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer | |
| DK1244438T3 (da) | Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde | |
| DK1224161T3 (da) | Nitroxyderivater af (R)- og (S)-carnitin | |
| DK1152763T3 (da) | Anvendelse af desozypeganin til behandling af stofafhængighed | |
| TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
| BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението | |
| PT900082E (pt) | Utilizacao de piridilpiperazina e pirimidilpiperazina para o fabrico de um medicamento para o tratamento de perturbacoes de toxicomania | |
| PT1082116E (pt) | Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento | |
| ATE334982T1 (de) | 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- | |
| CA2387394A1 (en) | Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder | |
| EE200100193A (et) | 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises |